NEWPORT PHARMACEUTICALS &lt;NWPH> 3RD QTR LOSS

  Period ended January 31.
      Shr loss six cts vs profit one ct
      Net loss 536,000 vs profit 166,000
      Revs 2,099,000 vs 3,149,000
      Avg shrs 10,429,000 vs 9,943,000
      Nine Mths
      Shre loss nine cts vs loss five cts
      Net loss 790,000 vs loss 377,000
      Revs 7,089,000 vs 7,646,000
      Avg shrs 10,406,000 vs 9,351,000
      Note: Full name Newport Pharmaceuticals International Inc.
  

